NCT00440583
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Siriraj Hospital, Mahidol University Bangkoknoi, Bangkok, Thailand
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
NCT00338494
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States
Completed
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
NCT00060684
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- Greater Baltimore Medical Center Baltimore, Maryland, United States
- New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL
NCT00274742
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Disease Attributes, +15 more
- Locations
-
- Medizinische Klinik 5, Hämatologie & Internistische Onkologie, Universitätsklinikum Erlangen Erlangen, Germany
- Universitätsklinikum Essen, Klinik für Hämatologie, Medizinische Klinik und Poliklinik Essen, Germany
- Universtätsklinkum Tübingen Tübingen, Germany
- Universitätsklinikum Ulm, Abteilung Innere Medizin III Ulm, Germany
NCT00323934
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- The Johns Hopkins Hospital Baltimore, Maryland, United States
- Princess Margaret Hospital Toronto, Ontario, Canada
- Hopital Charles LeMoyne Greenfield Park, Quebec, Canada
Completed
Intrathecal Bolus Doses of Ziconotide
NCT01373983
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
- Locations
-
- Pain and Rehabilitation Centre, University Hospital Linköping, Sweden
Completed
Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
NCT00220285
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Maebashi, Gunma, Japan
- Kanazawa, Ishikawa-ken, Japan
NCT00082784
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina Charleston, South Carolina, United States
Completed
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
NCT00099255
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California at Los Angeles Los Angeles, California, United States
- Stanford University Stanford, California, United States
- Yale New Haven, Connecticut, United States
NCT01015911
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center / University of California at Los Angeles Los Angeles, California, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States